Roche Boasts Of Tecentriq's Broad Potential In 3Q Earnings Update

 
• By Lucie Ellis-Taitt
  
Quality Quantity
Roche is at a 'unique time for both the quantity and quality of medicines' in its oncology portfolio • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business